← Open Payments lookup

ASHLEIGH GASPARAC: Open Payments

NPI 1912386418 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,004 in 41 payments from 11 companies in 2025. Trend: 2023 $321 · 2024 $421 · 2025 $2,004

Food & beverage: $2,004
CompanyPaymentsAmount
ABBVIE INC.27$637
Vanda Pharmaceuticals Inc.3$314
Neurocrine BioSciences, Inc.2$211
Lilly USA, LLC2$132
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$121
Noven Therapeutics, LLC1$120
Collegium Pharmaceutical, Inc.1$120
Alkermes, Inc.1$116
Axsome Therapeutics, Inc.1$116
Teva Pharmaceuticals USA, Inc.1$101

Products named: VRAYLAR, FANAPT, INGREZZA, ZEPBOUND, CAPLYTA, Xelstrym, Jornay PM, LYBALVI.

Industry payments across KY — which companies pay providers there.